Who owns Repare Therapeutics Ord?
- CUSIP Number: 760273102
Tip: Access positions for across all investors
Analyze quarterly positions in Repare Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Repare Therapeutics Ord stock
Who bought or sold Repare Therapeutics Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 10M | $18M | 0% | Sep 2025 |
|
| Blue Owl Capital Holdings | 3.4M | $9.0M | 0% | Dec 2025 |
|
| OrbiMed Advisors | 3.3M | $8.6M | 0% | Dec 2025 |
|
| Redmile Group | 1.6M | $2.8M | 0% | Sep 2025 |
|
| Rangeley Capital | 1.3M | $3.3M | 99% | Dec 2025 |
|
| MPM Asset Management | 1.1M | $2.0M | 0% | Sep 2025 |
|
| Marshall Wace | 1.1M | $2.9M | 100% | Dec 2025 |
|
| Renaissance Technologies | 981k | $2.6M | 36% | Dec 2025 |
|
| Citadel Advisors | 699k | $1.2M | -27% | Sep 2025 |
|
| Acadian Asset Management | 619k | $1.6M | 9% | Dec 2025 |
|
| Jane Street | 372k | $967k | 100% | Dec 2025 |
|
| Yakira Capital Management | 267k | $693k | 100% | Dec 2025 |
|
| Northern Trust | 260k | $677k | -1% | Dec 2025 |
|
| Equitec Proprietary Markets | 249k | $648k | 100% | Dec 2025 |
|
| Susquehanna International | 208k | $542k | 93% | Dec 2025 |
|
| BlackRock | 144k | $375k | -2% | Dec 2025 |
|
| Militia Capital Partners | 119k | $310k | 0% | Dec 2025 |
|
| XTX Topco | 117k | $304k | 146% | Dec 2025 |
|
| Walleye Trading Advisors | 107k | $277k | 100% | Dec 2025 |
|
| Point72 Asset Management | 51k | $133k | 100% | Dec 2025 |
|
| Hrt Financial | 42k | $109k | 100% | Dec 2025 |
|
| Quinn Opportunity Partners | 40k | $104k | 0% | Dec 2025 |
|
| FNY Investment Advisers | 35k | $91k | 100% | Dec 2025 |
|
| NewEdge Wealth | 33k | $86k | 0% | Dec 2025 |
|
| Two Sigma Advisers | 28k | $49k | 0% | Sep 2025 |
|
| Blackstone Group | 26k | $46k | 0% | Sep 2025 |
|
| Virtu Financial | 16k | $40k | 100% | Dec 2025 |
|
| Squarepoint Ops | 15k | $38k | -78% | Dec 2025 |
|
| Covestor | 14k | $35k | 100% | Dec 2025 |
|
| Occudo Quantitative Strategies | 14k | $35k | 100% | Dec 2025 |
|
| HarbourVest Partners | 12k | $22k | 0% | Sep 2025 |
|
| Engineers Gate Manager | 12k | $30k | 1% | Dec 2025 |
|
| Two Sigma Investments | 11k | $19k | -66% | Sep 2025 |
|
| Intl Fcstone | 11k | $28k | 100% | Dec 2025 |
|
| CIBC World Markets | 11k | $27k | 0% | Dec 2025 |
|
| Stifel Financial | 10k | $26k | -87% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 2.3k | $5.9k | 772% | Dec 2025 |
|
| SBI Securities | 1.3k | $3.3k | -1% | Dec 2025 |
|
| TD Waterhouse Canada | 1.3k | $3.3k | 0% | Dec 2025 |
|
| Barclays | 530.00 | $1.4k | 100% | Dec 2025 |
|
| Curio Wealth | 500.00 | $1.3k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 200.00 | $0 | -29% | Sep 2025 |
|
| Jones Financial Companies, L.L | 100.00 | $260.000000 | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 11.00 | $29.000400 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 4.00 | $7.000000 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.00 | $3.000000 | 0% | Dec 2025 |
|
Who sold out of Repare Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Versant Venture Management | Sep 2025 | 2.6M | $4.7M |
| MPM Oncology Impact Management | Sep 2025 | 820k | $1.4M |
| Millennium Management | Jun 2025 | 408k | $567k |
| Affinity Asset Advisors | Sep 2025 | 200k | $352k |
| Vontobel Holding | Sep 2025 | 40k | $70k |
| Ieq Capital | Sep 2025 | 38k | $68k |
| Lantern Wealth Advisors | Sep 2025 | 20k | $35k |
| Prudential Financial | Sep 2025 | 15k | $26k |
| GSA Capital Partners | Sep 2025 | 14k | $24k |
| SRS Capital Advisors | Sep 2025 | 13k | $22k |
| UBS Group | Sep 2025 | 3.6k | $6.3k |